Edibles vs. Inhalation: The Science of How Your Body Processes Medical Marijuana

One of the most common questions patients ask when starting medical marijuana is deceptively simple: should I use edibles or inhale? The answer seems like it should be a matter of preference. It's not. The two routes of administration produce fundamentally different pharmacological experiences — different onset times, different peak effects, different durations, and literally different active molecules reaching your brain.

Understanding this isn't optional trivia. It's the difference between effective symptom management and a 6-hour ordeal because you took too much of something your body processed differently than you expected.

The Basics: Two Very Different Journeys

When you inhale medical marijuana — whether through vaporization or smoking — cannabinoids enter your lungs, cross into the pulmonary blood supply, and reach your brain within minutes. The process largely bypasses the liver.

When you eat an edible, cannabinoids travel through your digestive system, get absorbed through the intestinal wall, and pass through the liver before reaching systemic circulation. This is called first-pass metabolism, and it changes everything.

Inhalation Pharmacokinetics

Absorption and Onset

Inhaled THC crosses the alveolar membrane in the lungs and enters arterial blood directly. Peak plasma concentrations occur within 3 to 10 minutes. You feel the effects almost immediately because the THC reaches your brain without detour.

A 1997 study by Huestis et al. in the Journal of Analytical Toxicology characterized the pharmacokinetics of smoked THC in detail. After smoking a joint containing 33.8 mg of THC:

• Peak plasma THC was reached at a mean of 8 minutes
• Maximum concentration averaged 162 ng/mL
• The rapid spike was followed by a steep decline as THC redistributed into fatty tissues

Bioavailability

The bioavailability of inhaled THC — the percentage that reaches systemic circulation — ranges from approximately 10% to 35%, depending on inhalation technique. A 2007 review by Grotenhermen in Clinical Pharmacokinetics noted that experienced users tend to achieve higher bioavailability through deeper inhalation and longer breath-holding, though the latter provides diminishing returns after about 3-5 seconds.

Vaporization generally provides higher bioavailability than smoking because it avoids combustion, which destroys a significant portion of the cannabinoids. A 2016 study by Spindle et al. found that vaporization delivered approximately 17-44% higher blood THC levels than smoking the same amount of flower.

Duration

The effects of inhaled medical marijuana typically last 2 to 4 hours, with peak effects occurring in the first 30-60 minutes. The relatively short duration makes inhalation useful for acute symptom management — breakthrough pain, sudden anxiety, nausea episodes — where you want rapid onset and reasonable predictability about when the effects will subside.

The THC Molecule You're Getting

When you inhale, the primary psychoactive molecule reaching your brain is delta-9-THC — the same molecule that was in the plant. Your liver does metabolize some of it after it enters systemic circulation, but the initial and peak effects are driven by delta-9-THC itself.

Oral (Edible) Pharmacokinetics

First-Pass Metabolism: The Game Changer

When THC enters the liver through the portal vein after oral ingestion, it encounters cytochrome P450 enzymes — specifically CYP2C9 and CYP3A4 — that metabolize it extensively before it reaches systemic circulation.

The result: a significant portion of the THC you swallowed gets converted to 11-hydroxy-THC (11-OH-THC) before it ever reaches your brain.

This matters enormously because 11-hydroxy-THC is not the same drug as delta-9-THC. It's a distinct metabolite with distinct properties.

11-Hydroxy-THC: The Edible Molecule

11-OH-THC crosses the blood-brain barrier more efficiently than delta-9-THC. A 1973 study by Lemberger et al. in Science — yes, we've known this for over 50 years — found that intravenous 11-OH-THC produced psychoactive effects that were significantly more intense than equivalent doses of intravenous delta-9-THC.

Key differences between the two molecules:

| Property | Delta-9-THC (Inhaled) | 11-OH-THC (Edibles) |

|----------|----------------------|---------------------|

| Blood-brain barrier penetration | Moderate | Higher |

| Subjective potency (mg for mg) | Baseline | Estimated 1.5-7x stronger |

| Onset | 3-10 minutes | 30-120 minutes |

| Duration | 2-4 hours | 4-8+ hours |

| Anxiogenic potential | Dose-dependent | Higher at equivalent doses |

| Sedation profile | Moderate | Stronger |

This is why edibles hit different. It's not just that they take longer to kick in. Your liver is creating a more potent, longer-acting, more CNS-penetrant compound.

Absorption and Onset

Oral THC absorption is slow and variable. Factors that affect it include:

• Stomach contents: Fat-soluble cannabinoids absorb better with food, particularly fatty foods. A 2019 study by Birnbaum et al. in Epilepsia (using CBD, but the principle applies to THC) found that high-fat meals increased cannabinoid absorption by up to 4-fold.
• Gastric emptying rate: Conditions, medications, or meals that slow gastric emptying delay absorption further.
• Individual metabolic variation: CYP2C9 and CYP3A4 activity varies significantly between individuals due to genetics. Some people are rapid metabolizers (producing more 11-OH-THC quickly), others are slow metabolizers (experiencing delayed and prolonged effects).

Peak blood levels from edibles typically occur between 1 and 3 hours after ingestion, but can be delayed up to 4-6 hours in some individuals. This is the pharmacokinetic basis for the classic edible mistake: taking a dose, feeling nothing after an hour, taking another dose, and then experiencing the cumulative effects of both doses simultaneously.

Bioavailability

Oral THC bioavailability is low — approximately 4% to 12% — because of extensive first-pass metabolism. However, the lower parent-drug bioavailability is partly offset by the higher potency of the 11-OH-THC metabolite.

A 2018 study by Barrus et al. in Annals of the New York Academy of Sciences noted that the ratio of 11-OH-THC to delta-9-THC in blood is approximately 0.5-3:1 after oral administration, compared to 0.1-0.3:1 after inhalation. When you eat an edible, a substantial proportion of what's actually affecting your brain is the metabolite, not the original molecule.

Duration

The effects of edibles typically last 4 to 8 hours, with some patients reporting residual effects for up to 12 hours. This extended duration can be therapeutic for chronic conditions requiring sustained symptom management — chronic pain, insomnia, spasticity — but makes dosing errors more consequential.

Sublingual: The Middle Ground

Sublingual (under the tongue) and oromucosal (inside the cheek) administration partially bypasses first-pass metabolism. Cannabinoids absorbed through the oral mucosa enter the bloodstream directly through capillaries, avoiding the liver on the first pass.

In practice, sublingual products produce:

• Onset in 15-45 minutes (faster than edibles, slower than inhalation)
• A mix of delta-9-THC and 11-OH-THC (because some of the product is inevitably swallowed and undergoes first-pass metabolism)
• Duration of 4-6 hours
• More predictable absorption than edibles

Sublingual tinctures are often a good starting point for patients who want to avoid inhalation but need more predictable pharmacokinetics than edibles.

CBD: Different Molecule, Same Principles

CBD follows similar pharmacokinetic patterns but with important differences:

• CBD oral bioavailability is approximately 6-13% (similarly low to THC)
• CBD is metabolized primarily by CYP2C19 and CYP3A4 to 7-OH-CBD, which has distinct pharmacological activity
• CBD is a potent inhibitor of CYP2C19 and CYP3A4, which means it can affect the metabolism of other drugs you're taking — and also affect THC metabolism when the two are taken together
• CBD does not produce intoxication regardless of route, but its anxiolytic, anti-inflammatory, and anticonvulsant effects still vary by administration method

Practical Implications for Patients

Choosing Based on Condition

Inhalation is generally better for:

• Acute symptom episodes (breakthrough pain, panic attacks, sudden nausea)
• Conditions requiring rapid onset and titration (you can take a small puff and wait)
• Patients who need to know exactly when effects will start and stop
• Daytime use when you need to remain functional on a predictable timeline

Edibles are generally better for:

• Chronic conditions requiring sustained relief (overnight pain, insomnia, sustained anxiety)
• Patients who cannot or prefer not to inhale
• Situations where long duration of action is an advantage
• Conditions where the deeper sedation profile of 11-OH-THC may be beneficial

Sublingual is generally better for:

• Patients who want a middle ground between onset speed and duration
• Those who need more predictable dosing than edibles
• Patients who want to avoid both inhalation and the variability of GI absorption

The Dosing Difference

Because of the bioavailability differences and the 11-OH-THC conversion, equivalent doses are not the same across routes. A general (approximate) equivalence:

• 10 mg inhaled THC ≈ 5-7.5 mg oral THC in effect
• Start lower with edibles (2.5-5 mg for naive patients)
• Wait at least 2 hours before re-dosing an edible — ideally 3-4 hours

Florida's medical marijuana program allows certified patients to access multiple routes of administration. At CORAL, Dr. Kim discusses the pharmacokinetic differences during the evaluation process so you can make an informed choice about which route makes sense for your specific symptoms.

Individual Variation

Some patients are genetic rapid metabolizers of THC (high CYP2C9 activity) — they convert oral THC to 11-OH-THC quickly and experience faster, more intense edible effects. Others are slow metabolizers who may not feel edible effects for 3-4 hours.

This genetic variation is one reason why the standard advice — "start low and go slow" — is more than a cliche. It's a pharmacokinetic necessity, especially with edibles.

Food Interactions

If you're using edibles, what you eat with them matters:

• High-fat meals significantly increase absorption (up to 4x in some studies)
• Empty stomach reduces and delays absorption
• Alcohol increases THC absorption and can amplify both intoxication and side effects — this combination should be approached with extreme caution

The Bottom Line

Edibles and inhalation are not interchangeable delivery methods for the same drug. They produce different active molecules (delta-9-THC vs. 11-OH-THC), different time courses, and different subjective experiences. Understanding these differences is essential for safe and effective use of medical marijuana.

The route of administration should be a deliberate clinical decision based on your condition, your symptoms, your lifestyle, and your individual response — not a guess.

If you're exploring medical marijuana and want guidance on which route of administration might work best for your specific needs, you can schedule a consultation at [coral.clinic/start](https://coral.clinic/start). Dr. Kim walks every patient through these pharmacokinetic considerations as part of developing a personalized treatment approach.